W.J. Gullick

1.0k total citations
17 papers, 883 citations indexed

About

W.J. Gullick is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W.J. Gullick has authored 17 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W.J. Gullick's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). W.J. Gullick is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). W.J. Gullick collaborates with scholars based in United Kingdom, United States and Switzerland. W.J. Gullick's co-authors include Josephine C. Adams, Michael D. Waterfield, Julian Downward, Thomas S. Frank, Barbara L. Weber, Mary Codd, M O'Regan, Amanda McCann, D N Carney and P. Dervan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

W.J. Gullick

17 papers receiving 861 citations

Peers

W.J. Gullick

ONCOL

RNMI

PRM

L. C. Padhy India

P.M. Wencyk United Kingdom

Erika Yorida Canada

Andrew Berchuck United States

Shirley M. Walker United States

Frank Mross Switzerland

Samuel W. Brady United States

Duen‐Hwa Yan United States

Carlo Gatti Italy

S. Edgerton United States

L. C. Padhy India

W.J. Gullick

490 ×0.8

ONCOL

530 ×1.2

267 ×1.0

RNMI

151 ×1.0

49 ×0.5

PRM

Citations per year, relative to W.J. Gullick W.J. Gullick (= 1×) peers L. C. Padhy

Countries citing papers authored by W.J. Gullick

Since Specialization

Citations

This map shows the geographic impact of W.J. Gullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.J. Gullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.J. Gullick more than expected).

Fields of papers citing papers by W.J. Gullick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.J. Gullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.J. Gullick. The network helps show where W.J. Gullick may publish in the future.

Co-authorship network of co-authors of W.J. Gullick

This figure shows the co-authorship network connecting the top 25 collaborators of W.J. Gullick. A scholar is included among the top collaborators of W.J. Gullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.J. Gullick. W.J. Gullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Harrington, Kevin J., et al.. (2004). Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model. British Journal of Cancer. 91(2). 366–373. 11 indexed citations

Gullick, W.J., et al.. (1998). Expression of the c-erbB-4/her-4 growth factor receptor in breast cancer. European Journal of Cancer. 34. S37–S37. 2 indexed citations

Autzen, P, et al.. (1997). Cripto-1 is a tumour specific marker of bladder cancer. 80. 23. 1 indexed citations

Rajkumar, Thangarajan, Gordon Stamp, Christine M. Hughes, & W.J. Gullick. (1996). c-erbB3 protein expression in ovarian cancer. Molecular Pathology. 49(4). M199–M202. 31 indexed citations

Saeki, Toshiaki, David S. Salomon, Gibbes R. Johnson, et al.. (1995). Association of Epidermal Growth Factor-related Peptides and Type I Receptor Tyrosine Kinase Receptors with Prognosis of Human Colorectal Carcinomas. Japanese Journal of Clinical Oncology. 25(6). 240–9. 72 indexed citations

Rajkumar, Thangarajan, Donal Hollywood, Helen C. Hurst, & W.J. Gullick. (1995). c-erbB3 expression in breast tumour derived cell lines. The Breast. 4(2). 84–91. 3 indexed citations

Onagbesan, O.M., et al.. (1994). Immunohistochemical localization of epidermal growth factor receptors, epidermal-growth-factor-like and transforming-growth-factor-α-like peptides in chicken ovarian follicles. Reproduction. 102(1). 147–153. 29 indexed citations

Molina, Rafael, Daniel R. Ciocca, Amol Tandon, et al.. (1993). Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.. PubMed. 12(6B). 1965–71. 49 indexed citations

Sanidas, Elias, M. I. Filipe, Jacqueline M. Linehan, et al.. (1993). Expression of the c‐erbB‐3 gene product in gastric cancer. International Journal of Cancer. 54(6). 935–940. 31 indexed citations

10.

Gullick, W.J., et al.. (1993). Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.. PubMed. 53(3). 627–35. 148 indexed citations

11.

Johnson, G R, S A Prigent, W.J. Gullick, & Kurt Stromberg. (1993). Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity.. Journal of Biological Chemistry. 268(25). 18835–18843. 29 indexed citations

12.

Gasparini, Giampietro, W.J. Gullick, Pierantonio Bevilacqua, et al.. (1992). Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.. Journal of Clinical Oncology. 10(5). 686–695. 87 indexed citations

13.

McCann, Amanda, P. Dervan, M O'Regan, et al.. (1991). Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.. PubMed. 51(12). 3296–303. 152 indexed citations

14.

Gerber, H., G. Locher, Aron Goldhirsch, et al.. (1990). c-erbB-2 protein expression in node negative breast cancer. Annals of Oncology. 1(4). 263–268. 31 indexed citations

15.

Gullick, W.J., et al.. (1990). Oncoprotein stability after tumour resection. British Journal of Cancer. 61(4). 538–542. 21 indexed citations

16.

Adams, Josephine C. & W.J. Gullick. (1989). Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines. Biochemical Journal. 257(3). 905–911. 89 indexed citations

17.

Gullick, W.J., Julian Downward, & Michael D. Waterfield. (1985). Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.. The EMBO Journal. 4(11). 2869–2877. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact